According to Reuters, the grocery retailer notified Express Scripts in September 2022 of its plan to terminate the pharmacy ...
Biomed Industrie, Inc. logo NA-931 for weight loss Biomed pipeline Biomed Industries, Inc. Engages with Medicare to Advan ...
Kroger's healthcare unit said on Wednesday it would resume services for customers of Cigna's pharmacy benefits manager Express Scripts, more than two years after ending an agreement with the company.
Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.
Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in licensing deals, on average, than in 2023 with an eye toward enriching their ...
Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...
Learn more about whether Biogen Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...
The Company has recently announced execution of an agreement for $27 million in funding for HOPE Clinic Acquisition. Upon closing of the first tranch ...
Cheap stocks represent an opportunity to supercharge our portfolios. Dr James Fox details several deemed undervalued by ...
Dr Jitendra Singh is the minister of state for science and technology and earth sciences Exclusive Interview/ Dr Jitendra Singh, minister of state for science and technology and earth sciences IN ...
Beijing Primegene Therapeutics Co. Ltd. has synthesized Mas-related G-protein coupled receptor member X2 (MRGPRX2) antagonists reported to be useful for the treatment of urticaria and asthma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results